Octreotide for cirrhosis after variceal bleeding. Authors' claims for octreotide were not justified
- PMID: 9596609
- PMCID: PMC1113210
- DOI: 10.1136/bmj.316.7144.1607
Octreotide for cirrhosis after variceal bleeding. Authors' claims for octreotide were not justified
Comment on
-
Randomised trial of octreotide for long term management of cirrhosis after variceal haemorrhage.BMJ. 1997 Nov 22;315(7119):1338-41. doi: 10.1136/bmj.315.7119.1338. BMJ. 1997. PMID: 9402774 Free PMC article. Clinical Trial.
References
-
- Primignani M, Andreoni B, Carpinelli L, Capria A, Rocchi G, Lorenzini I, et al. Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: a randomized, double-blind, placebo controlled, multicentre trial. Hepatology. 1995;21:1322–1327. - PubMed
-
- Freedman LS. Tables of the number of patients required in clinical trials using the log rank test. Stat Med. 1982;1:121–129. - PubMed
-
- Vorobioff J, Groszmann RJ, Picabea E, Gamen M, Villavicenzio R, Bordato J, et al. Prognostic value of hepatic venous pressure measurement in alcoholic cirrhosis: a 10 year prospective study. Gastroenterology. 1996;111:701–709. - PubMed
-
- Coleman J, Cromie S, Jones P, Dudley E, Dudley F. Clinical relevance of sequential portal pressure measurements in alcoholic cirrhosis. Hepatology. 1997;26:316. .
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical